Suspended Indian wrestler Sumit Malik on Tuesday said he has no idea how a banned stimulant entered his body but admitted that he was on painkillers during the recent Olympic Qualifiers and had informed the world body about that before taking the mat.
The 2018 Commonwealth Games gold-medallist was handed a provisional suspension by the United World Wrestling (UWW) after a specified banned substance -- 5-methylhexan-2amine (1,4 dimethylpentylamine) -- was found in his sample.
Malik had secured the 125kg category quota for the Tokyo Olympic during the Olympic Qualifiers, held in Sofia, Bulgaria, last month but was handed suspension for failing his dope test during the same tournament.
"There was severe pain in my knee and I had taken painkillers Mobizox and Voveran. I had informed the UWW officials about it. I have taken the same painkillers before also, I don't know how I tested positive," Malik told PTI.
"UWW people have also informed me that the quantity of the substance is less than one per cent. It's merely 0.5 per cent. They have told me that a clear picture will be given to me in 3-4 days," he added.
While Malik asserted that he has taken only these twopain killers, AIIMS senior resident doctor Uditi Gupta said that none of them contains any stimulant.
"Neither Mobizox nor Voveran contains any stimulant. It might be there in some other protein supplements he was taking.
"Voveran is a single drug that contains only diclofenac, which is a painkiller while Mobizox is a combination drug which is a painkiller and a muscle relaxant but there is no stimulant in it," Gupta said.
"Methylhexanamine (found in Malik's sample) is a stimulant. It is sometimes used for nasal decongestion but never for pain relief," she added.
Asked if he consulted a doctor before taking the medicines, Malik conceded that he did not.
"No, I did not ask anyone. I took it on my own. I have taken these painkillers before also but never tested positive.
"Now they tell me that they have found something in my pre-workout sample also but did not tell me what it is," Malik, who gave consent for testing his B sample on June 9, said.
Malik, who has to pay Rs 1.5 lakh for testing of the B sample, is hoping to come out clean.
"People who are handling it, tell me that it's not a drug, it's not something heavy. I am hopeful I will be cleared and I will be able to compete in the Olympics," the 28-year-old from Rohtak said.
Sports Lawyer Parth Goswami said if Malik wants any relief in this case, he must establish the source of the substance found in his body.
"The athlete can get benefit of exoneration, reprimand or reduced sanction only if he can establish the source of the substance which was found in his sample and further establish that such consumption was not intentional," he explained.
"The athlete will have to prove that there was no fault or negligence on his part while consuming such prohibited substance.
"In order to participate in Tokyo, Sumit will have to move fast and try to expedite the hearing process," he said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)